Finnish spinal cord injury rehabilitation research using Nexstim SmartFocus™ technology receives significant funding from Wings for Life Foundation

News
- 26/06/2019

Helsinki, Finland: 26 June 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated, personalised and non-invasive brain stimulation systems for diagnostics and therapy – today announces that Helsinki University Hospital in Finland has received significant funding from the renowned Wings for Life foundation to continue its research into spinal cord injury rehabilitation using Nexstim’s SmartFocusTM  technology.

Wings for Life specifically supports international research focused on finding new treatment methods for spinal cord injury patients whose rehabilitation is known to be highly challenging.

More info on Nexstim’s website